11 results
Pulmonary Embolism Treatment
Systemic Thrombolysis
 - Exclude contraindications.
 - Indications:
   - Massive PE (definite indication)
submassive PE (risk ... 50mg IV) - 2% risk ... of ICH and 6% risk ... who are higher risk ... AcutePE #Management #CriticalCare
Azithromycin - since there has been a lot of noise around chloroquine/hydroxychloroquine, thought we can take
for COVID-19… ... azithromycin has a long ... for potential DIs ... QT prolongation risk ... #Management #Pharmacology
In ARDS, we know that the lungs are so diffusely injured that the remaining total area
In ARDS, we know ... 3-4 ml/kg, the risk ... to minimize the risk ... #foamed #criticalcare ... #treatment #respiratory
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... and exacerbation risk ... of expiration; ICS ... #Pharmacology
COVID-19 - Subpleural Consolidations on Lung POCUS

Doing daily POCUS LUS for ICU COVID-19 patients in Singapore
Consolidations on Lung ... POCUS LUS for ICU ... Spare the risk to ... #clinical #lung ... #ultrasound #pulmonary
Stress Ulcer Prophylaxis

Stress ulcerations are common in ICU patients and may lead to hemorrhage if not
are common in ICU ... ulceration or treatment ... Pathophysiology • Risk ... #Prophylaxis #criticalcare ... #pharmacology #
Volume Assist/Control Mechanical Ventilation
How does this mode work?
 • Delivers a set volume of air with
for providing Lung ... patients with ARDS ... (or at high risk ... ventilation #AC #criticalcare ... #pulmonary
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Risk Factors and ... Prognostic Markers • Risk ... no consensus on risk ... Avoid ARBsICD ... Risk of recurrence
The crusade against “Ab”Normal Saline continues.  This is a non-physiologic fluid that can harm our
The ECF and ICF ... with an increased risk ... #foamed #criticalcare ... management #diagnosis #treatment ... #pharmacology #
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
effusion, INC risk ... Malignancy Risk ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... lubricants • Pharmacologic